Company intelligence / Profile preview

Boops Pets

New York, New York, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Boops is a pet health and longevity company dedicated to extending the healthy lifespan of dogs through science-backed nutrition and supplements. The company's flagship product, The Daily Boop, is a comprehensive supplement designed to support joint health, cognitive function, and cellular vitality in aging canines. By leveraging research into the biological pathways of aging, Boops aims to provide pet owners with proactive health solutions that go beyond standard pet nutrition. The company operates at the intersection of veterinary science and consumer wellness, emphasizing high-quality ingredients and transparent sourcing to optimize pet health spans.

Therapeutic areas: RheumatologyOtherNeurologyImmunology
Modalities: NutraceuticalSmall moleculeBotanical extract
Industry: Veterinary

Beyond the preview

Go deeper on Boops Pets.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Boops Pets.

Explore the full profile